Means Investment Co., Inc. Gilead Sciences, Inc. Transaction History

Means Investment Co., Inc.

$821 Million
Q2 2024

A detailed history of Means Investment Co., Inc. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Means Investment Co., Inc. holds 6,221 shares of GILD stock, worth $451,395. This represents 0.05% of its overall portfolio holdings.

Number of Shares

6,221

Previous 6,293 1.14%

Holding current value

$451,395

Previous $460,000 7.39%

% of portfolio

0.05%

Previous 0.06%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 19, 2024	SELL	$63.15 - $72.88 $4,546 - $5,247	-72 Reduced 1.14%	6,221 $426,000
Q1 2024 Apr 17, 2024	SELL	$71.58 - $87.29 $28,202 - $34,392	-394 Reduced 5.89%	6,293 $460,000
Q4 2023 Jan 25, 2024	SELL	$73.27 - $83.09 $7,986 - $9,056	-109 Reduced 1.6%	6,687 $541,000
Q3 2023 Oct 25, 2023	SELL	$73.94 - $80.67 $4,066 - $4,436	-55 Reduced 0.8%	6,796 $509,000
Q2 2023 Jul 31, 2023	SELL	$76.01 - $86.7 $9,577 - $10,924	-126 Reduced 1.81%	6,851 $528,000

Q1 2023 May 08, 2023	SELL	$77.31 - $88.08 $4,561 - $5,196	-59 Reduced 0.84%	6,977 $578,000
Q4 2022 Jan 27, 2023	SELL	$62.32 - $89.47 $11,404 - $16,373	-183 Reduced 2.53%	7,036 $0
Q3 2022 Oct 17, 2022	BUY	$59.54 - $68.01 $36,974 - $42,234	621 Added 9.41%	7,219 $445,000
Q2 2022 Jul 21, 2022	BUY	$57.72 - $65.01 $4,444 - $5,005	77 Added 1.18%	6,598 $408,000
Q1 2022 Apr 26, 2022	BUY	$57.92 - $72.58 $926 - $1,161	16 Added 0.25%	6,521 $388,000
Q4 2021 Feb 14, 2022	SELL	$64.88 - $73.64 $1,167 - $1,325	-18 Reduced 0.28%	6,505 $472,000
Q3 2021 Nov 12, 2021	SELL	$67.69 - $73.03 $19,494 - $21,032	-288 Reduced 4.23%	6,523 $456,000
Q2 2021 Aug 10, 2021	SELL	$63.47 - $69.35 $6,093 - $6,657	-96 Reduced 1.39%	6,811 $469,000
Q1 2021 Apr 05, 2021	SELL	$60.0 - $68.46 $4,740 - $5,408	-79 Reduced 1.13%	6,907 $446,000
Q4 2020 Feb 12, 2021	SELL	$56.65 - $64.55 $54,044 - $61,580	-954 Reduced 12.02%	6,986 $467,000
Q3 2020 Nov 09, 2020	SELL	$62.1 - $78.08 $38,502 - $48,409	-620 Reduced 7.24%	7,940 $469,000
Q2 2020 Aug 13, 2020	SELL	$72.34 - $84.0 $1,663 - $1,932	-23 Reduced 0.27%	8,560 $583,000
Q1 2020 Apr 23, 2020	BUY	$62.63 - $80.22 $46,471 - $59,523	742 Added 9.46%	8,583 $698,000
Q4 2019 Jan 21, 2020	SELL	$61.62 - $67.78 $28,838 - $31,721	-468 Reduced 5.63%	7,841 $494,000
Q3 2019 Nov 05, 2019	SELL	$62.51 - $69.0 $75,949 - $83,835	-1,215 Reduced 12.76%	8,309 $542,000
Q2 2019 Aug 07, 2019	SELL	$61.87 - $69.38 $16,086 - $18,038	-260 Reduced 2.66%	9,524 $645,000
Q1 2019 Apr 16, 2019	SELL	$62.53 - $70.05 $48,710 - $54,568	-779 Reduced 7.37%	9,784 $636,000
Q4 2018 Apr 16, 2019	BUY	$60.54 - $79.0 $639,484 - $834,477	10,563 New	10,563 $661,000

Others Institutions Holding GILD

# of Institutions

1,892

Shares Held

Call Options Held

8.71M

Put Options Held

8.02M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $90.9B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Means Investment Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on Means Investment Co., Inc. with notifications on news.

Account

Means Investment Co., Inc. Gilead Sciences, Inc. Transaction History